Fumapharm

Develops therapeutics for the treatment of psoriasis and multiple sclerosis.

Launch date

1983

Lucerne Canton of Lucerne (HQ & founding location)

Date	Investors	Amount	Round
May 2006	Biogen	N/A	Acquisition
May 2012	Royalty Pharma	$761m	Acquisition
Total Funding		-

Recent News about Fumapharm